{"database": "openregs", "table": "documents", "rows": [["FDA-2013-D-0576-0030", "FDA", "FDA-2013-D-0576", "Reference 10 Additional Safeguards for Children in Clinical Investigations of Food and Drug Administration_Regulated Products 78FedReg12937 2-26-13 re Considerations for the Design of Early-Phase Clinical Trials of Cellular and Gene Therapy Products; Guidance for Industry", "Supporting & Related Material", "Background Material", "2015-06-11T04:00:00Z", 2015, 6, null, null, "2015-06-11T14:26:55Z", null, 0, 0, "0900006481b2c9dd"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2013-D-0576-0030"], "units": {}, "query_ms": 8.993018884211779, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}